Pfizer Maintains Dividend as PFE Stock Navigates Patent Cliff and Oncology Pipeline Development
Pfizer Inc. has declared a quarterly dividend of $0.42 per share, maintaining the payout rate ahead of what the company has described as a transitional period for its product portfolio. The New York-based pharmaceutical giant […]
